ArticleFrontiers in oncology2025
A multi-data fusion deep learning model for prognostic prediction in upper tract urothelial carcinoma.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic performance of radiomics for detecting and characterising upper tract urothelial carcinoma (UTUC): a systematic review.World journal of urology · 2026Pooled it
- Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making.Frontiers in oncology · 2026Review
- Management and Treatment Strategies for Upper Tract Urothelial Carcinoma: Current Insights.Research and reports in urology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Upper tract urothelial carcinoma (UTUC) is a rare but highly invasive urinary malignancy with a high postoperative recurrence rate. Methods: We retrospectively collected data from 133 UTUC patients who underwent radical nephroureterectomy between 2005 and 2017. Patients were divided into a training set (n=103) and a testing set (n=30). A multi-modal deep learning model named Multi-modal Image-Clinical Combination Classifier (MICC) was developed by integrating multi-phase contrast-enhanced CT imaging and clinical data. The model's prognostic performance was compared with two unimodal models-ImageNet (CT-based) and ClinicalNet (clinical data-based)-and traditional clinical parameters including pathological T stage. Feature importance was evaluated using SHapley Additive exPlanations (SHAP). Results: The MICC model achieved superior prognostic accuracy with AUCs of 0.918 and 0.895 in the training and testing sets, respectively, outperforming unimodal models. Classification metrics were robust, with accuracy of 0.854, sensitivity of 0.889, specificity of 0.836, negative predictive value (NPV) of 0.933, and positive predictive value (PPV) of 0.744. Precision-recall analysis confirmed strong identification of high-risk patients despite dataset imbalance. SHAP analysis highlighted that CT imaging features contributed most significantly to the model's predictions. Conclusion: Integrating multi-phase CT imaging with clinical data, the MICC model provides accurate prognostic prediction for UTUC patients. This approach has potential to assist clinicians in personalized risk stratification and treatment planning, ultimately improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.